Madison Asset Management LLC Invests $3.93 Million in Synopsys, Inc. $SNPS

Madison Asset Management LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the second quarter, HoldingsChannel.com reports. The firm purchased 8,818 shares of the semiconductor company’s stock, valued at approximately $3,933,000.

Other hedge funds have also made changes to their positions in the company. Sankala Group LLC purchased a new stake in shares of Synopsys during the 4th quarter valued at about $25,000. Elevation Wealth Partners LLC increased its position in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the last quarter. IMG Wealth Management Inc. acquired a new stake in Synopsys during the second quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys during the 4th quarter valued at approximately $28,000. Finally, Atlas Capital Advisors Inc. acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $32,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insiders Place Their Bets

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.

Synopsys Stock Down 0.8%

SNPS stock opened at $397.92 on Friday. The company has a 50-day moving average of $420.85 and a two-hundred day moving average of $440.51. The stock has a market capitalization of $76.19 billion, a price-to-earnings ratio of 92.11, a price-to-earnings-growth ratio of 2.36 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the firm posted $3.67 earnings per share. Synopsys’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities research analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Robert W. Baird set a $558.00 target price on Synopsys in a research report on Thursday, May 28th. Morgan Stanley dropped their price target on Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a report on Wednesday. Citigroup upped their price objective on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. BNP Paribas Exane increased their price objective on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, KeyCorp reissued an “overweight” rating on shares of Synopsys in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $563.59.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.